SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-020566
Filing Date
2018-11-13
Accepted
2018-11-13 16:06:36
Documents
53
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20180930_10q.htm 10-Q 666945
2 EXHIBIT 3.1 ex_127455.htm EX-3.1 30485
3 EXHIBIT 31.1 ex_127368.htm EX-31.1 10233
4 EXHIBIT 31.2 ex_127369.htm EX-31.2 10480
5 EXHIBIT 32.1 ex_127370.htm EX-32.1 5005
6 EXHIBIT 32.2 ex_127371.htm EX-32.2 5001
  Complete submission text file 0001437749-18-020566.txt   3886462

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT dffn-20180930.xml EX-101.INS 776548
8 XBRL TAXONOMY EXTENSION SCHEMA dffn-20180930.xsd EX-101.SCH 41360
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20180930_cal.xml EX-101.CAL 37999
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20180930_def.xml EX-101.DEF 281004
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20180930_lab.xml EX-101.LAB 252395
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20180930_pre.xml EX-101.PRE 300654
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 181177957
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1